Showing results (91-100 of 230) with videos related to
Sort By:
Pageof 23
Magnetic Resonance Imaging|July 17, 2012
Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trialsRobert K Doot, Tove Thompson, Benjamin E Greer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2004
High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumesJoseph G Rajendran, Darrell R Fisher, Ajay K Gopal, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest doseJoseph G Rajendran, Ajay K Gopal, Darrel R Fisher, et al.Tomography (Ann Arbor, Mich.)|April 30, 2021
Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687Mark Muzi, Finbarr O'Sullivan, Timothy G Perk, et al.The Journal of Urology|September 5, 2018
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE TrialGerald L Andriole, Lale Kostakoglu, Albert Chau, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2010
Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastasesRobert K Doot, Mark Muzi, Lanell M Peterson, et al.Academic Radiology|August 21, 2002
Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapyStephanie E Stafford, Julie R Gralow, Erin K Schubert, et al.Radiology. Imaging Cancer|October 21, 2022
18F-FDG PET/CT for the Evaluation of Therapy Response in Hormone Receptor-Positive Bone-Dominant Metastatic Breast CancerIgor Makhlin, Katrina Esther Korhonen, Melissa Lynne Martin, et al.Annals of Surgical Oncology|June 15, 2007
Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancerMichelle S Yao, Brenda F Kurland, Anne H Smith, et al.American Journal of Clinical Oncology|August 4, 2004
Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC)Jennifer R Bellon, Robert B Livingston, William B Eubank, et al.Pageof 23